ARCELLX INC

NASDAQ: ACLX (Arcellx, Inc.)

Last update: 3 days ago, 7:43PM

66.37

1.09 (1.67%)

Previous Close 65.28
Open 65.10
Volume 348,239
Avg. Volume (3M) 467,612
Market Cap 3,567,766,016
Price / Sales 29.89
Price / Book 9.38
52 Weeks Range
30.88 (-53%) — 75.10 (13%)
Profit Margin -37.23%
Operating Margin (TTM) -127.79%
Diluted EPS (TTM) -1.04
Quarterly Revenue Growth (YOY) 91.50%
Total Debt/Equity (MRQ) 15.25%
Current Ratio (MRQ) 6.01
Operating Cash Flow (TTM) -20.01 M
Levered Free Cash Flow (TTM) -32.63 M
Return on Assets (TTM) -7.43%
Return on Equity (TTM) -13.80%

Market Trend

Short Term Medium Term
Industry Biotechnology (US) Mixed Mixed
Biotechnology (Global) Mixed Mixed
Stock Arcellx, Inc. Bullish Bullish

Stockmoo Score

1.2
Analyst Consensus 5.0
Insider Activity -1.5
Price Volatility 2.0
Technical Moving Averages -1.5
Technical Oscillators 2.0
Average 1.20

Similar Stocks

Stock Market Cap DY P/E P/B
ACLX 4 B - - 9.38
CRNX 5 B - - 5.60
RARE 5 B - - 11.25
AXSM 4 B - - 42.94
DYN 3 B - - 3.98
VERA 2 B - - 6.83

Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.

Sector Healthcare
Industry Biotechnology
Investment Style Small Growth
% Held by Insiders 12.75%
% Held by Institutions 95.55%

Ownership

Name Date Shares Held
Sr One Capital Management, Lp 30 Jun 2024 2,346,630
Cormorant Asset Management, Lp 30 Jun 2024 1,525,000
Suvretta Capital Management, Llc 30 Jun 2024 1,516,254
52 Weeks Range
30.88 (-53%) — 75.10 (13%)
Price Target Range
96.00 (44%) — 122.00 (83%)
High 122.00 (Stifel, 83.82%) Buy
Median 115.00 (73.27%)
Low 96.00 (Needham, 44.64%) Buy
Average 111.00 (67.24%)
Total 3 Buy
Avg. Price @ Call 94.20
Firm Date Target Price Call Price @ Call
Needham 22 Oct 2024 96.00 (44.64%) Buy 90.46
09 Aug 2024 81.00 (22.04%) Buy 59.05
Stifel 18 Oct 2024 122.00 (83.82%) Buy 96.86
Canaccord Genuity 17 Oct 2024 115.00 (73.27%) Buy 95.27
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
PATEL KAVITA - 90.46 -1,500 -135,690
Aggregate Net Quantity -1,500
Aggregate Net Value ($) -135,690
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 90.46
Name Holder Date Type Quantity Price Value ($)
PATEL KAVITA Director 22 Oct 2024 Automatic sell (-) 1,500 90.46 135,690
PATEL KAVITA Director 22 Oct 2024 Option execute 1,500 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria